What is the recommended cefepime dosing for adults (including dosing for severe versus less severe infections) and pediatric patients, and how should the dose be adjusted in renal impairment?

Cefepime Dosing

For adults with normal renal function, cefepime should be dosed at 2 g IV every 8 hours for serious infections (particularly Pseudomonas or high-MIC pathogens), with dose reduction required proportionally to declining creatinine clearance to prevent neurotoxicity.

Adult Dosing

Standard Dosing by Indication 1

Severe infections (pneumonia, febrile neutropenia, complicated intra-abdominal infections):

• 2 g IV every 12 hours for moderate infections
• 2 g IV every 8 hours for severe infections or suspected Pseudomonas 1

Uncomplicated UTI and skin infections:

• 0.5-1 g IV every 12 hours 1

Critical Care Considerations

In ICU patients with preserved renal function (CrCl >50 mL/min), higher doses than standard are often required 2. Studies show that:

• Standard doses achieve PK-PD targets in only 16-44% of critically ill patients 2
• Doses >4 g/day may be needed for high-MIC organisms (MIC ≥4 mg/L) 2, 3
• Extended infusions (3-hour infusion) improve target attainment for organisms with MIC 4-8 mg/L 3

Critical pitfall: Patients with augmented renal clearance (CrCl >120 mL/min) may require 2 g every 6 hours to maintain adequate concentrations 3.

Renal Dose Adjustments

Cefepime clearance correlates linearly with creatinine clearance 4. Adjust as follows 1, 3:

• CrCl >120 mL/min: 2 g every 6 hours (for severe infections)
• CrCl 60-120 mL/min: 2 g every 8 hours
• CrCl 30-60 mL/min: 2 g every 12 hours
• CrCl 11-29 mL/min: 2 g every 24 hours
• CrCl <10 mL/min: 1 g every 24 hours

Dialysis Dosing

Intermittent hemodialysis: 1 g every 24 hours (given after dialysis on dialysis days) 5

Continuous renal replacement therapy (CRRT): 2 g every 12 hours 5. The drug is significantly cleared by CRRT, with clearance proportional to effluent flow rates 6.

Pediatric Dosing

Infants and Children (2 months to 16 years) 7, 1

Standard dosing:

• 50 mg/kg IV every 8 hours (maximum 2 g/dose) 7, 1

For Pseudomonas or severe infections:

• 50 mg/kg IV every 8 hours, up to maximum 2 g/dose 7

Neonatal Dosing 7

Gestational age <36 weeks:

• 30 mg/kg IV every 12 hours

Gestational age ≥36 weeks:

• 50 mg/kg IV every 12 hours

Critical Safety Considerations

Neurotoxicity Risk

Cefepime has moderate pro-convulsive activity (160% relative to penicillin G) 2. Risk factors include:

• Trough concentrations >20 mg/L 2, 8
• Renal impairment, even with dose adjustment 8
• Symptoms: confusion, myoclonus, non-convulsive status epilepticus 8

Two patients (10%) in one ICU study developed neurotoxicity despite renal dose adjustment when trough levels reached 20-30 mg/L 8. Symptoms resolved promptly after drug discontinuation.

Monitoring Recommendations

Therapeutic drug monitoring should be considered when:

• CrCl <30 mL/min (high accumulation risk) 8
• Treating organisms with MIC ≥4 mg/L (inadequate exposure risk) 9, 8
• Any neurological symptoms develop 8

Target: Maintain free drug concentrations >MIC for ≥60% of dosing interval, but keep trough <20 mg/L to minimize neurotoxicity risk 3, 8.

Efficacy Concerns

Clinical failure rates increase significantly when treating organisms with MIC ≥4 mg/L 9. Even with CLSI-recommended doses, odds ratios for clinical failure were:

• MIC 4 mg/L: OR 9.13 (p<0.01)
• MIC 8 mg/L: OR 6.79 (p=0.01)

For MIC 4-8 mg/L, consider alternative agents or ensure higher dosing regimens (2 g every 8 hours minimum) with extended infusions 9.

Administration

Prolonged or continuous infusions (3-4 hour infusions) are recommended for infections with high-MIC organisms to maximize time above MIC 2, 3.